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Organismal development requires the precise coor-
dination of genetic programs to regulate cell fate
and function. MEF2 transcription factors (TFs) play
essential roles in this process but how these broadly
expressed factors contribute to the generation of
specific cell types during development is poorly
understood. Here we show that despite being
expressed in virtually all mammalian tissues, in the
retina MEF2D binds to retina-specific enhancers
and controls photoreceptor cell development.
MEF2D achieves specificity by cooperating with a
retina-specific factor CRX, which recruits MEF2D
away from canonical MEF2 binding sites and redi-
rects it to retina-specific enhancers that lack the
consensus MEF2-binding sequence. Once bound
to retina-specific enhancers, MEF2D and CRX
co-activate the expression of photoreceptor-specific
genes that are critical for retinal function. These
findings demonstrate that broadly expressed TFs
acquire specific functions through competitive
recruitment to enhancers by tissue-specific TFs
and through selective activation of these enhancers
to regulate tissue-specific genes.
INTRODUCTION
A remarkable feature of the development of complex multicel-
lular organisms is that this extraordinary process is controlled
by a limited number of transcription factors (TFs). TFs regulate
the exquisite patterns of gene expression that determine the tis-
sues and cell types of an organism. The diversity of TF function is
especially evident in the CNS, where a vast array of different cell
types gives rise to our ability to extract information from the
external environment, process that information, and respondappropriately. While a number of TFs with tissue-specific
expression have been identified, most TFs function in a wide
range of cell types, yet can still contribute to cell-type-specific
gene expression. The best evidence that broadly expressed
TFs contribute to cell-type-specific functions is that mutations
in broadly expressed TFs may result in tissue-specific disease
phenotypes (Amiel et al., 2007; Bienvenu et al., 2013). Neverthe-
less, it is not yet well understood how the function of widely
expressed TFs is tailored to achieve cell-type specificity. Eluci-
dating the mechanisms that specify the function of a broadly
expressed TF within a given tissue is critical for understanding
how genes are differentially regulated to achieve the diversity
of cell types throughout the organism.
The highly conservedmyocyte enhancer factor-2 family of TFs
(MEF2A-D) is expressed in virtually all cells of multi-cellular
organisms yet plays specific and critical roles in the development
of the brain, muscle, bone, and hematopoietic lineages (re-
viewed in Potthoff and Olson, 2007). In the mammalian nervous
system, MEF2 factors regulate neural progenitor differentiation,
neurotrophin- and activity-dependent neuronal survival, activ-
ity-dependent restriction of excitatory synapse number, as well
as synaptic plasticity and behavior (Barbosa et al., 2008; Cole
et al., 2012; Flavell et al., 2006; Li et al., 2008; Pulipparacharuvil
et al., 2008; Shalizi et al., 2006). In humans, mutations in MEF2C
can lead to severe intellectual disability, epilepsy, and an
absence of speech (Bienvenu et al., 2013). Despite their clear
importance in the nervous system and many other tissues, rela-
tively little is known about how these globally expressed TFs
achieve cell-type-specific functions in the development of the
nervous system and a wide range of other tissues.
One clue as to howMEF2 familymembers achieve their tissue-
specific functions has been provided by identification of MEF2
target genes in distinct tissues. Gain- and loss-of-function ap-
proaches and a limited number of chromatin immunoprecipita-
tion assays have shown that MEF2 controls the transcription
of synaptic regulatory proteins such as Arc and Syngap1 in
neurons, Myog in myocytes, and Il2 in hematopoietic cells,
among other genes (Flavell et al., 2008; Pan et al., 2004; Potthoff
and Olson, 2007; Sebastian et al., 2013). While to date noNeuron 86, 247–263, April 8, 2015 ª2015 Elsevier Inc. 247
experiments have directly compared MEF2 target genes across
different tissues, these findings suggest that MEF2 functions at
least in part by regulating distinct target genes in different cell
types. However, the mechanisms by which the tissue-specific
targets of MEF2 are determined remain poorly understood.
The effect of MEF2 on gene expression in a given cell type
must be determined in part by where MEF2 binds across the
genome. MEF2 family members are known to recognize and
bind to a common consensus DNA motif ((C/T)TA(A/T)4TA(A/G))
termed theMEF2-responsive element (MRE) (Potthoff and Olson
2007; Flavell et al., 2008). In vitro experiments indicate that DNA
sequences that conform to this consensus site bind MEF2 with
higher affinity compared to non-consensus sequences (Pollock
and Treisman, 1991). These findings have led to the suggestion
that MEF2 binding in a cell might be inferred from the presence
of strong consensus MREs within the promoters or enhancers
of genes whose expression is altered when MEF2 function is in-
hibited.MEF2 could therefore achieve tissue-specific function by
binding to consensus MREs that are differentially accessible in
each tissue due to the unique chromatin landscape of that tissue.
Alternatively, MEF2 could bind to the same regulatory elements
in all tissues, but function at just a subset of these sites in a given
tissue. Significant innovations in high-throughput sequencing
technology now make it possible to identify sites of TF binding
genome-wide and to assess the activity of each bound region
(Creyghton et al., 2010; Johnson et al., 2007; Kim et al., 2010;
Rada-Iglesias et al., 2011); however, these approaches have
not yet been used to determine whether or howMEF2 selectively
regulates enhancers or promoters in a tissue-specific manner.
Once bound to anMRE that is present in an enhancer or target
gene promoter, MEF2 is believed to either repress or activate
nearby target genes, largely through interactions with co-factors
such as histone acetyltransferases and histone deacetylases
(Potthoff and Olson, 2007). In addition, it has been suggested
that in myocytes MEF2 family members work together with mus-
cle-specific bHLH factors to regulate gene expression (Molken-
tin et al., 1995).While severalmodels for the possible functions of
this interaction have been proposed, including cooperative bind-
ing or cooperative activation, the endogenous mechanisms by
which MEF2 interacts with co-factors to regulate target genes
in a tissue-specific manner remain unknown.
To determine how a widely expressed TF such as MEF2 regu-
lates tissue-specific gene expression during key steps in
mammalian CNS development, we identified a cell type in the
CNS, the photoreceptor cells of the mouse retina, where a single
MEF2 family member, MEF2D, is predominantly expressed. A
newly generated loss-of-function allele forMef2d revealed a crit-
ical role for MEF2D in mouse retinal photoreceptor development
and in the regulation of cell-type-specific gene expression,
including genes that are mutated in human retinal diseases.
In vivo genomic and phenotypic analyses demonstrate that
MEF2D regulates cell-type-specific gene expression in photore-
ceptors by binding to cell-type-specific enhancers together with
the homeodomain TF CRX. Analysis of MEF2D binding and
enhancer activation in Crx knockout (KO) retinas revealed that
CRX biases a genome-wide competition among enhancers for
MEF2D binding. In wild-type (WT) retinas, CRX recruits MEF2D
to tissue-specific enhancers that lack the consensusMEF2 bind-248 Neuron 86, 247–263, April 8, 2015 ª2015 Elsevier Inc.ing sites, thus redirecting MEF2D away from strong MREs. Once
bound to retina-specific enhancers, MEF2D and CRX work
cooperatively to activate the expression of photoreceptor-spe-
cific genes that are critical for retina function. Together, these
findings demonstrate that broadly expressed TFs can acquire
tissue-specific functions through competitive recruitment to en-
hancers by tissue-specific TFs and through selective activation
of these enhancers to regulate tissue-specific target genes.
RESULTS
Mef2d Is Required Cell Autonomously for Photoreceptor
Development and Function
To address how the broadly expressedMEF2 TF family achieves
tissue-specific function in the CNS, we focused our studies on a
single family member, Mef2d, that is widely expressed and has
been implicated in critical aspects of neural development (Flavell
et al., 2006, 2008). We first sought to identify a region of the CNS
where MEF2D is the predominant family member expressed and
therefore is not likely to be functionally redundant with other
MEF2 family members. We reasoned that such a region could
serve as an experimental system for understanding the
context-dependent role of MEF2D in neuronal development.
An investigation of MEF2 expression in the cortex, hippocam-
pus, and cerebellum revealed that the major cell types of these
regions co-express MEF2 family members (data not shown).
We therefore turned to the retina, whose well-characterized
and spatially separated cell types might allow us to identify a
cell type that exclusively expresses MEF2D. We found that
both MEF2A and MEF2D are expressed in the developing retina
(Figure 1A). In contrast, MEF2C is only expressed after retinal
development is complete. While MEF2A and MEF2D are co-
expressed at different levels relative to one another in retinal neu-
rons such as horizontal, bipolar, amacrine, and retinal ganglion
cells (Figure 1B), the ratio of MEF2D to MEF2A expression ap-
pears to be highest in maturing photoreceptor cells in the outer
nuclear layer (ONL) (Figure 1B). In these cells, MEF2D is distrib-
uted in a pattern consistent with nuclear localization and binding
to active euchromatin (Corbo et al., 2010). Retinal photoreceptor
cells are a specialized class of primary sensory neurons that
detect the incidence of photons upon the retina and transduce
this event into a neural signal for processing by downstream re-
gions of the visual system. Given the importance of MEF2 family
members in neuronal development, we hypothesized that
MEF2D may play a critical role in the development of photore-
ceptor cells and that characterization of this role might yield
important insights into the cell-type-specific functions of MEF2
factors.
To explore the role of MEF2D in photoreceptors, we generated
a Mef2d knockout allele in which the first five protein-coding
exons of Mef2d, including the entirety of the highly conserved
MADS and MEF2 DNA-binding and dimerization domains,
were removed (Figures S1A–S1F). This allele differs from a pre-
viously generated mutant allele ofMef2d, in which only the sec-
ond coding exon of Mef2d was removed (Kim et al., 2008). This
previously generated allele results in a highly expressed trun-
cated protein product with a partial DNA binding domain. The
presence of this residual protein product could potentially
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Figure 1. MEF2D Is Required Cell Autono-
mously for Photoreceptor Development
and Function
(A) Immunoblot of MEF2 family member expres-
sion in mouse retina over development.
(B) Immunofluorescence of P25 WT retinal cross-
sections for MEF2A (red) and MEF2D (green) with
DAPI (blue). Inset highlights rod photoreceptor
nuclei. ONL, outer nuclear layer; INL, inner nuclear
layer; GCL, ganglion cell layer.
(C) Toluidine blue-stained cross-sections of WT
and Mef2d KO littermate retinas. OS, photore-
ceptor outer segments; IS, photoreceptor inner
segments.
(D) Representative electroretinograms (ERGs) from
a P21 WT mouse and aMef2d KO littermate under
dark-adapted (DA) and light-adapted (LA) condi-
tions.
(E) Representative immunofluorescence images
of P21 retinas electroporated at P0 for sparse
expression of Cre recombinase and GFP (green) in
either Mef2dfl/+ or Mef2dfl/fl mice. ABCA4 immu-
nostaining (red) was used to identify photoreceptor
cell outer segments (OS).
(F) Quantification of OS from GFP-positive photo-
receptors as shown in (E). Mean GFP intensity in
the ABCA4-positive region (OS GFP) was normal-
ized to mean GFP intensity in the inner segments
(IS GFP) to measure OS development while con-
trolling for electroporation density (Mef2dfl/+, n = 6;
Mef2dfl/fl, n = 3 retinas). Error bars represent SEM.complicate the interpretation of phenotypes in these mice. This
potential problem is eliminated in the new line of conditional
MEF2D knockout mice, termed Mef2dD2-6 (Figures S1A–S1F).
These mice were crossed with the germline EIIA:cre deleter
strain to produce a stable constitutive knockout line. The
absence of MEF2D expression in all cells of the retina was
confirmed by immunofluorescence. This constitutive Mef2d
knockout line, referred to below as Mef2d KO, was used for all
subsequent analyses, except where noted.
Mef2d KOmice are born in Mendelian ratios and are fertile but
exhibit a slightly decreased body weight compared to WT litter-
mates (p = 1.35e-6; Figure S1G). While MEF2D is expressed
throughout the CNS, the brains of Mef2d KO mice appear
normal, most likely due to compensation by other MEF2 familyNeuron 86, 247members. By contrast, the retinas of
Mef2d KO mice display a significant
defect in the maturation of rod and cone
photoreceptors. At postnatal day 11
(P11)Mef2dKO retinas are grossly normal
and contain all major cell types. However,
by P21, Mef2d KO photoreceptor cells
differ strikingly from WT photoreceptors
in that they lack the outer segment
structures that are necessary for vision
(Figure 1C). Photoreceptor cell outer seg-
ments are an apical organelle of stacked
membranous discs in which phototrans-
duction occurs and where the cascadeof neuronal signaling that underlies the visual response to light
begins. The development of these structures normally occurs
between P11 and P28, which corresponds to the functional
maturation of photoreceptor cells. The failure of outer segment
development in Mef2d KO retinas should lead to a deficit in
photoreceptor cell function. Correspondingly, in vivo electroreti-
nograms (ERGs) performed at P21 revealed that visual re-
sponses are almost completely absent in Mef2d KO mice
compared with WT littermates in both dark- and light-adapted
conditions (Figures 1D and S1H). This indicates that both rod
and cone photoreceptor cells have markedly impaired function
in Mef2d KO mice. Very few apoptotic cells are present in
Mef2d KO retinas at P21; however, the failure of Mef2d KO
photoreceptor cells to develop normally eventually leads to a–263, April 8, 2015 ª2015 Elsevier Inc. 249
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Figure 2. MEF2D Directly Regulates Critical Cell-Type-Specific Targets and Disease Genes in the Retina
(A) RNA-seq average exon density for individual genes in P11 WT and MEF2D KO retinas are displayed in gray (n = 2 per genotype). Genes were considered
upregulated (green) or downregulated (red) only if expressed at >0.1 in 2WT or 2 KO samples, if KO/WT exon density wasR23 or <0.5, and if the log p value of the
difference of mean log-densities between KO and WT datasets < 0.05 (Student’s t test).
(legend continued on next page)
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slow retinal degeneration (Figure 1C). Taken together, these find-
ings indicate that MEF2D is required for photoreceptor cell
development, long-term survival, and vision.
Since MEF2D is the only MEF2 family member expressed in
retinal photoreceptors, the developmental failure of photorecep-
tors to form outer segments inMef2d KO retinas seems likely to
be due to a cell-intrinsic requirement forMef2d. However, to rule
out the possibility that a MEF2D-dependent alteration in the
extracellular environment during photoreceptor development is
responsible for the deficits observed, we selectively removed
Mef2d from individual developing photoreceptors by sparsely
introducing Cre recombinase into MEF2Dfl/fl photoreceptors us-
ing in vivo electroporation. We found that at P21 photoreceptors
in which the expression of MEF2D is disrupted have highly
abnormal outer segments when compared to photoreceptors
still expressing MEF2D (Figures 1E, 1F, and S1I). The abnormal
morphology was also reproduced in photoreceptors where
Mef2d shRNA was selectively introduced in an otherwise WT
retina (Figures S1J–S1L). Finally, the disruption of photoreceptor
development was reversed when the Mef2d shRNA was co-ex-
pressed with an shRNA-resistant form of Mef2d (Figures S1M
and 1N). Taken together, these findings suggest that MEF2D
functions cell autonomously to promote photoreceptor develop-
ment and that, in the absence of MEF2D, photoreceptors fail to
mature, are non-functional, and ultimately die.
MEF2D Directly Regulates Critical Cell-Type-Specific
Targets and Disease Genes in the Retina
Given that MEF2D is a TF, it is likely that the gene targets of
MEF2D regulate aspects of photoreceptor development and
function. One possibility is that MEF2D regulates photore-
ceptor-specific target genes that encode proteins necessary
for photoreceptor development and function. Alternatively, since
MEF2 family members are expressed in a multitude of different
tissues, it could be that MEF2D controls photoreceptor differen-
tiation by regulating a core set of target genes that are shared
across cell types. To distinguish between these possibilities,
we carried out a series of experiments to identify and charac-
terize the direct targets of MEF2D in the retina. We reasoned
that a gene must meet three criteria to be considered a direct
target. First, candidate target genes must be misregulated in
Mef2d KO retinas. Second, target genes must have MEF2D
bound at their promoters or associated enhancers. Third, the
binding of MEF2D at those promoters or enhancers must be
required for proper regulation of direct target genes. Genes
that met each of these three criteria were defined as bona fide
targets of MEF2D in the retina.(B) ChIP-seq signal at 2,403 high-confidence MEF2D genomic binding sites for tw
site is represented as a single horizontal line (purple) centered on the peak sum
according to peak size.
(C) UCSC genome browser tracks for MEF2D ChIP-seq and RNA-seq experimen
Guca1b genomic locus.
(D) Distribution of MEF2D binding (magenta triangles) in the retina as determined
(gray) are aligned at their transcriptional start sites (TSS, black line). MEF2D bind
target genes in the retina. Gene loci are ordered according to the distance of ME
(E) Luciferase reporter assays performed in retinal explants to determine the acti
(scrm) or Mef2d shRNA knockdown or with mutated MEF2D-binding sites (MRE
(F) Examples of direct MEF2D target genes relevant to photoreceptor cell biologTo begin to identify the targets genes of MEF2D, we first per-
formed high-throughput RNA sequencing (RNA-seq) of total
RNA from WT and Mef2d KO retinas at P11 (Figures 2A, S2A,
and S2B). At P11, MEF2D is strongly expressed but WT and
Mef2d KO retinas are morphologically indistinguishable. Thus,
differences in gene expression between WT and Mef2d KO
retinas at P11 should be primarily due to the disruption of
MEF2D-dependent transcriptional programs rather than due to
cell attrition or the secondary effects of disrupted retinal devel-
opment.We find that the expression ofmost genes is unchanged
whenWT andMef2d KO P11 retinas are compared (Spearman’s
correlation coefficient r = 0.989) (Figure 2A). However, a subset
of 185 genes is strongly misregulated in Mef2d KO retinas (Fig-
ures 2A and S2C; Table S1). This set of misregulated genes is
significantly enriched for retina-specific genes (modified Fisher’s
exact test; p = 5e-9) according to the DAVID web tool (Huang
et al., 2009a, 2009b). Furthermore, gene ontology (GO) analysis
found that these misregulated genes are most enriched for
genes involved in processes such as visual perception and sen-
sory perception of a light stimulus (modified Fisher’s exact test;
p = 1.51e-4 and p = 1.59e-4, respectively) (Figure S2D). This
analysis is most consistent with the hypothesis that MEF2D pro-
motes photoreceptor development by regulating a network of
genes essential for photoreceptor function rather than a com-
mon set of core target genes shared across cell types and
tissues.
To determine with high confidence which candidate MEF2D
target genes had MEF2D bound at their promoters or nearby
enhancers, we performed two bioreplicates ofMEF2D chromatin
immunoprecipitation sequencing (ChIP-seq) using P11wild-type
retinas and performed MEF2D ChIP-seq inMef2d KO retinas as
a control for specificity. Because the majority of cells in the
mouse retina are photoreceptors (73%–80%), it is likely that
the vast majority of identified MEF2D binding sites represent
MEF2D binding in photoreceptors instead of other retinal cell
types (Young, 1985; Jeon et al., 1998). Each MEF2D ChIP-seq
replicate alone yielded 12,000 unique MEF2D binding sites
with an overlap of 4,000 reproducible binding sites between
the two replicates, demonstrating that a high degree of biological
or technical noise is inherent to these experiments. The number
of high-confidence MEF2D binding sites was further decreased
to 2,403 when we considered only those peaks that are specif-
ically reduced in the Mef2d knockout (Figures 2B and S2E). Of
these sites, 400 MEF2D binding sites were identified as pro-
moters, while 2,003 were identified as genetic enhancers as
they are located >1,000 bp away from the transcriptional start
site (TSS) of the nearest gene. This suggested that MEF2Do WT and one MEF2D KO experiment from P11 retinas. Each MEF2D binding
mit. Intensity of color correlates with peak size. MEF2D peaks are ordered
ts as well as DNase hypersensitivity (DHS) data (ENCODE Consortium) at the
by ChIP-seq with respect to 71 candidate target genes. Target gene bodies
s at promoters (open triangles) and/or enhancers (filled triangles) of candidate
F2D binding to the TSS.
vity of WT MEF2D-bound target gene enhancers or promoters with scrambled
mut) (Student’s t test; *p value < 0.05; **p value < 0.01; n.s., not significant).
y. Genes implicated in human retinal diseases are highlighted in blue.
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acts chiefly as enhancers in photoreceptor cells. Strikingly, 2,403
is a large number ofMEF2D binding sites compared to 185 highly
misregulated target genes, suggesting that only a small number
of theMEF2D-bound sites actively regulate gene expression.We
next asked which of these MEF2D binding sites were proximal to
genes that are highly misregulated in theMef2d KO. MEF2D was
found to bind at 18 promoter regions and 75 enhancers near
genes that are highlymisregulated inMef2dKO retinas, including
many genes that are photoreceptor-specific and associated with
retinal diseases (Monte Carlo analysis, p < 13 105, Figures 2C,
2D, and S2E). Thus, MEF2D appears to regulate many of its
photoreceptor-specific targets by binding at proximal regulatory
elements, particularly at enhancers.
To test whether direct binding of MEF2D to the promoters or
enhancers of candidate target genes is required for proper
gene expression, we isolated a subset of these elements that
contained consensus MREs and tested the ability of these
enhancers to regulate reporter gene expression in the intact
retina in aMEF2D-dependent manner. All seven of the regulatory
elements that were tested are sufficient to drive reporter gene
expression in photoreceptor cells and six out of seven are
expressed exclusively in photoreceptor cells but not in other
retinal cells as determined by electroporation of GFP-expressing
reporters into the developing retina (data not shown). Addition-
ally, the activity of six out of seven of these reporters was signif-
icantly reduced in the presence of Mef2d shRNA or when the
MRE was mutated as determined by electroporation of lucif-
erase reporters into the developing retina, demonstrating that
direct MEF2D binding to these elements is required to drive
expression of the reporter gene (Figure 2E). The observation
that expression of one of the reporters is not decreased in the
presence of Mef2d shRNA, or when the MRE is mutated, sug-
gests that MEF2D may not directly regulate gene expression
through this candidate enhancer region or that this isolated
sequence does not fully recapitulate the endogenous regulation
of this enhancer by MEF2D. However, the analyses of the
remaining reporter constructs support the hypothesis that candi-
date target genes identified by RNA-seq and ChIP-seq are
indeed direct targets of MEF2D. This hypothesis was later
confirmed at endogenous MEF2D-bound enhancers in vivo, by
demonstrating that these enhancers lose markers of active
enhancers, H3K27Ac and eRNAs, in Mef2d KO retinas (Figures
6C and S6A).
Intriguingly, themost highly misregulatedMEF2D target genes
identified by these analyses have critical roles in photoreceptor
function (Figures 2F and S2C; Table S2). For example, Sag,
Gngt1, Arr3, Pde6h, Guca1a, and Guca1b are key components
of the phototransduction cascade. Misregulation of these tran-
scripts in combination would be expected to severely disrupt
phototransduction and is likely to be the primary cause of the
abnormal photoresponses in Mef2d KO mice. Indeed, human
mutations inSag,Pde6h,Guca1a, andGuca1b are all associated
with visual disorders (Fuchs et al., 1995; Kohl et al., 2012; Payne
et al., 1998; Sato et al., 2005). Other photoreceptor-specific
target genes that are not directly part of the phototransduction
cascade may contribute to the structural defects in outer
segment formation observed inMef2d KO retinas. For example,
Fscn2, a photoreceptor-specific actin-bundling protein, is252 Neuron 86, 247–263, April 8, 2015 ª2015 Elsevier Inc.mutated in retinitis pigmentosa and has been demonstrated to
be necessary for outer segment elongation (Wada et al., 2001;
Yokokura et al., 2005). Similarly, Pcdh15, a cadherin superfamily
member, has been implicated in vesicular trafficking between
the inner and outer segments and is mutated in a form of Usher
Syndrome (USH1F) characterized by visual impairment and
hearing loss (Cosgrove and Zallocchi, 2014). In contrast, MEF2
targets that have been identified in other neuronal cell types
such as Nur77, Arc, and Syngap1 (Flavell et al., 2008) are not
strongly expressed in the developing retina under normal condi-
tions. These analyses suggest that the primary function of
MEF2D in the retina is to regulate the expression of genes that
are critical for specific photoreceptor functions rather than genes
with common functions across cell types.
MEF2D Binds and Regulates Tissue-Specific Enhancers
with the Retina Co-Factor CRX
Wenext sought to understand themechanisms bywhichMEF2D
binds to and regulates its targets in photoreceptor cells. Eluci-
dating this mechanism is of special interest because many
MEF2D targets are essential for photoreceptor function and
are mutated in human diseases of the retina. The simplest and
most prevalent model of MEF2 function is that MEF2 binds to
MEF2 consensus binding sites (MREs) in the promoters or
enhancers of its target genes and thereby controls their expres-
sion (Edmondson et al., 1992; Sandmann et al., 2006). Given the
photoreceptor-specific expression of many MEF2D target
genes, in this model the binding of MEF2D would be expected
at MREs that are accessible in photoreceptors but not other
neuronal cell types. The ability of MEF2D to recognize and
bind to these photoreceptor-specific MREs would somehow
be specified during CNS development, for example, through
changes in DNA accessibility or through interaction with tis-
sue-specific co-factors. A second possibility is that MEF2D
binds to a common set of MREs accessible in all tissues and
that these bound elements are selectively activated in a tissue-
specific manner. To begin to distinguish between these possibil-
ities, we compared MEF2D binding across the retinal genome to
that observed in two distinct cell types where MEF2 factors are
known to play important roles.
To explore the possibility that MEF2 regulates cell-type-spe-
cific gene transcription by binding the genome in a cell-type-
specific manner, we performed ChIP-seq for MEF2D in day
in vitro 7 (DIV7) cultured cortical neurons and analyzed MEF2D
ChIP-seq data in C2C12 myocytes (Sebastian et al., 2013) and
compared these results to MEF2D ChIP-seq from the retina. A
comparison of MEF2D binding in each of the three tissues
showed that MEF2D binding to the enhancers and promoters
that are necessary for retinal-specific gene expression occurs
in a highly tissue-specific manner (82%, 76/93) (Figure 3A).
Furthermore, the majority of MEF2D binding genome-wide in
each tissue is tissue specific, although some instances of shared
binding did occur (Figures 3B, 3C, and S3). These findings sug-
gest that tissue-specific binding ofMEF2D is an important mech-
anism governing the specific function of MEF2D in the retina.
We next investigated the mechanism by which MEF2D
achieves tissue-specific binding to promoters and enhancers
in the retina. Previous studies have suggested that interactions
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Figure 3. MEF2D Binds at Tissue-Specific Enhancers in the Retina
(A) Percentage of MEF2D-bound near target genes that are retina specific or are also sites of MEF2D binding in DIV7 cultured cortical neurons or myotubes.
(B) Overlap ofMEF2D-bound genomic regions fromP11 retina, DIV7 cultured cortical neurons, and culturedmyotubes (fromSebastian et al., 2013) as determined
by ChIP-seq.
(C) UCSC genome browser tracks for MEF2D ChIP-seq from cultured myotubes, cortical neurons, or retina as well as genomic conservation at Esrrb and Hdac5
genomic loci.
(D and E) Position weight matrices (PWMs) of enriched TF binding motifs within MEF2D-bound regions specific to the retina or myotubes. Below each is a high-
ranking JASPAR (http://jaspar.genereg.net) matrix corresponding to the PWM (Hypergeometric test).
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between MEF2 family members and particular co-factors can in-
fluence the binding of MEF2D to a given regulatory element
(Black et al., 1996; Molkentin et al., 1995); however, it is unknown
whether these interactions mediate tissue-specific MEF2 bind-
ing and the functional importance of these interactions has not
been examined in vivo in an endogenous or genome-wide
context. We hypothesized that MEF2D interacts with a retina-
specific TF that recruits MEF2D to tissue-specific regulatory
sites. To begin to identify such co-factors in an unbiased
manner, we searched MEF2 binding sites in the retina for com-
mon DNA sequence features using a de novo DNA motif search
program (Heinz et al., 2010). This analysis revealed that after the
MRE, the most abundant motif sequence present within retina-
specific MEF2D-bound regions is the sequence TAATCNBNTT
(p = 1e-85) (Figure 3D). This sequence motif matches the binding
site for the homeodomain TF CRX (p = 3.59e-6). In contrast,
when we performed a de novo motif search of MEF2D-bound
regions identified in myocytes the most prevalent sequence,
besides the MRE, was CAGCTGTT (p = 1e-397). This is the
consensus binding motif for myogenic basic helix-loop-helix
(bHLH) proteins, such as MYOD (p = 7.41e-6; Figure 3E), which
have been suggested to be MEF2 co-factors in this cell type
(Molkentin et al., 1995). In cortical neurons, however, no single
recognizable motif was significantly enriched at MEF2D binding
sites apart from theMRE, likely due to the extreme heterogeneity
of these cells. These findings raise the possibility that the spec-
ificity of MEF2 binding in different tissues (e.g., photoreceptors
versus muscle) is determined by interactions with tissue-specific
co-factors. In particular, the enrichment of the CRX consensus
binding motif at retina-specific MEF2D binding sites suggests
that in photoreceptors CRX could influence the binding of
MEF2D to the promoters and enhancers of photoreceptor-
specific genes.
CRX is a retina-specific TF that is mutated in several forms
of human congenital blindness. Much like MEF2D, CRX is
necessary for photoreceptor outer segment development and
photoreceptor function (Chen et al., 1997; Freund et al., 1997;
Furukawa et al., 1997, 1999; Swain et al., 1997) and the loss-
of-function phenotypes of these two TFs in the mouse retina
closely resemble one another (Figure 1C; Furukawa et al.,
1999). These shared phenotypes and the enrichment of the
CRX motif at MEF2D-bound sites suggested that CRX protein
might bind and function with MEF2D at MEF2D-bound regulato-
ry elements to regulate common target genes and similar biolog-
ical processes.
To determine whether CRX acts with MEF2D to co-regulate
target genes, we first performed RNA-seq from WT and Crx
KO retinas at P11 (Figure S4). As previously observed, many
genes are misregulated in absence of CRX in the retina including
genes that are direct targets of MEF2D (Figures 4A, 4B, 4E, and
S4C; Table S2) (Hsiau et al., 2007; Tran et al., 2014). Next, we
analyzed CRX ChIP-seq data (Corbo et al., 2010) for overlap
with MEF2D ChIP-seq to determine whether CRX co-regulates
MEF2D target genes by co-binding to shared target gene en-
hancers and promoters. Strikingly, we found that70%of target
gene-associated MEF2D regulatory elements are co-bound
by CRX in the retina (Figures 4C and 4D). These findings sug-
gested that MEF2D may functionally interact with CRX to254 Neuron 86, 247–263, April 8, 2015 ª2015 Elsevier Inc.achieve tissue-specific binding or regulation of the promoters
and enhancers of photoreceptor genes.
CRX Biases a Genome-wide Competition for MEF2D
Binding toward Retina-Specific Sites
To test the possibility that CRX is required for retina-specific
MEF2D binding, we performed MEF2D ChIP-seq in Crx KO ret-
inas and compared the pattern of MEF2D binding to that of WT
retinas. By ChIP-seq, we found that MEF2D binding is reduced
more than 2-fold in Crx KO retinas at 339 MEF2D binding sites
including many MEF2D regulatory elements near MEF2D target
genes (Figures 5A, 5B, and S5A, red). For example, retina-spe-
cific MEF2D binding is particularly dependent on CRX near the
MEF2D target genesGngt1, a key component of the phototrans-
duction cascade, and Stard7, which has been shown to be
required for normal photoreceptor development (Hao et al.,
2012) (Figure 5B and data not shown). Mef2d is not, however,
a transcriptional target of CRX and therefore the decrease in
MEF2D binding at these sites is not due to decreased expression
of Mef2d in Crx KO retinas (Figure S5B).
Unexpectedly, we also found that MEF2D binding is increased
more than 2-fold in Crx KO retinas at a distinct set of 224 sites
genome-wide, demonstrating that MEF2D binding in photore-
ceptors is not merely lost at a subset of sites in Crx KO retinas
but instead that the binding of MEF2D is redistributed to other
sites across the genome (Figures 5A, 5B, and S5A, green).
Notably, many of the regions where MEF2D binding increases
in Crx KO retinas are not retina-specific enhancers but instead
are sites where MEF2D binds in other tissues (Figures 3B, 5B,
and S5C). These sites included an upstream enhancer of
Npas4, which is expressed in a stimulus-dependent manner in
cortical neurons, but is not expressed in the retina, and the pro-
moter of Srpk3, a gene that is an important target of MEF2 in
muscle (Figure 5B and data not shown) (Kim et al., 2010; Naka-
gawa et al., 2005). In contrast, MEF2D binding sites where
MEF2D binding decreases in Crx KO retinas are highly tissue
specific (Figure S5C).
This redistribution of MEF2D binding in Crx KO retinas occurs
predominately at regions that are already DNase hypersensitive
in WT retinas (Figures 5B and S5D), suggesting that loss of CRX
does not make these sites newly accessible but instead that
without CRX the distribution of MEF2D binding shifts to other
available sites. To determine whether this redistribution of
MEF2D binding has functional consequences for gene expres-
sion, we examined the expression of the nearest genes to sites
where MEF2D is lost or gained in the Crx KO. We observed
decreased gene expression near certain sites where MEF2D
binding is lost in the Crx KO (Figures 5B and S5E). This may be
directly due to the loss of MEF2D at these sites. Alternatively,
loss of CRX itself may contribute to this change. We also
observed increases in gene expression near some sites where
MEF2D binding increases in the Crx KO (Figures 5B and S5E).
This suggests that the redistribution of MEF2D in the Crx
KO has functional consequences on gene expression in
photoreceptors.
While MEF2D requires CRX for binding to many important en-
hancers, not all MEF2D binding is CRX dependent (Figures 5A
and 5B). We therefore hypothesized that MEF2D may only
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Figure 4. MEF2D and CRX Directly Co-Regulate Critical Shared Target Genes
(A and B) Average gene expression levels as quantified by exon density of MEF2D direct target genes in WT versusMef2d KO retinas (A) and WT versus Crx KO
retinas (B). n = 2 per genotype. Gray line indicates unity. Red lines indicate a 2-fold change from unity.
(C) UCSC genome browser tracks for MEF2D ChIP-seq and CRX ChIP-seq (Corbo et al., 2010) from WT retinas, as well as for RNA-seq from the retinas of P11
littermate WT and MEF2D KO or WT and CRX KO mice and DNase hypersensitivity data (ENCODE Consortium) at the Guca1b genomic locus.
(D) Distribution of MEF2D binding (magenta triangles) or MEF2D and CRX co-binding (blue triangles) as determined by ChIP-seq with respect to 71MEF2D target
genes. Target gene bodies (gray) are aligned at their transcriptional start sites (TSS, black line). Gene loci are ordered according to the proximity of the nearest
MEF2D binding to the TSS.
(E) Examples of shared direct MEF2D and CRX target genes relevant to photoreceptor cell biology. Genes implicated in human retinal diseases are in blue.
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Figure 5. CRX Mediates a Genome-wide Competition for MEF2D Binding to Retina-Specific Sites
(A) MEF2D ChIP-seq signal in WT versus CRX KO retinas at individual MEF2D-bound regions. Read density was calculated for the 400 bp window around
the summit of each MEF2D-bound region. Data from CRX KO retinas were compared to the data from three different WT retinas experiments. Peaks highlighted
are at least 0.53 reduced (red) or 23 increased (green) in CRX KO retinas as compared to the average ChIP-seq read value of the three WT samples. Black line
indicates unity.
(B) Stard7 (left), Pla2r1 (center), and Srpk3 (right) genomic loci with CRX ChIP-seq tracks from WT retinas, MEF2D ChIP-seq tracks from CRX WT and CRX KO
retinas, genomic conservation, DNase hypersensitivity tracks from retina (DHS, ENCODE), and RNA-seq tracks from WT and Crx KO retinas; MEF2D-bound
enhancers are highlighted according to the fold change of MEF2D binding in Crx KO versus WT retinas.
(legend continued on next page)
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require CRX to stabilize binding at regulatory elements with weak
consensus MREs. In support of this idea, we find that the
consensus MEF2D binding sequence is substantially de-
enriched in regions where MEF2D binding is CRX dependent
compared to sites where MEF2D binding is unchanged (Figures
5C and S5F). In contrast, regions where MEF2D binding
increases in the Crx KO are enriched for consensus MREs
relative to MEF2D binding sites where the level of MEF2D bind-
ing decreases in the absence of CRX (KS test, p = 4.76e-5) (Fig-
ures 5C and S5F). Taken together, these data strongly suggest
that in photoreceptor cells CRX recruits MEF2D away from
non-retinal consensus binding sites in favor of retina-specific
sites that do not require a consensus MRE. This appears to be
an important mechanism for achieving tissue-specific binding
of MEF2D so that MEF2D can regulate photoreceptor-specific
target genes.
MEF2D and CRX Co-Regulate Gene Expression
by Selective Activation of Retinal Enhancers
As described above, tissue-specific binding of MEF2D in the
retina together with CRX plays a critical role in specifying
the function of MEF2D in photoreceptor cells. However, of the
several thousand MEF2D-bound sites that we detect in the
retina, fewer than 4% are located near genes whose expression
is significantly altered in the absence of MEF2D. This suggests
that additional mechanisms must exist to determine which of
the many MEF2D-bound sites are functionally important in the
retina, possibly through the selective activation of MEF2D-
bound regulatory elements. This hypothesis is consistent with
previous genome-wide analyses that demonstrate that only a
small fraction of TF occupancy affects the expression of nearby
genes (Spitz and Furlong, 2012). We therefore sought to deter-
mine whether MEF2D regulates the expression of its target
genes through selective activation of enhancers and to identify
the mechanisms beyond binding to DNA that regulate the action
of MEF2D in photoreceptor cells.
To determine the subset ofMEF2D-bound regulatory sites that
are active, we identified the subset of MEF2D binding sites that
display features of active enhancers, acetylation of histone 3 at
lysine 27 (H3K27ac) and transcription of bidirectional enhancer
RNAs (eRNAs) (Creyghton et al., 2010; Kim et al., 2010; Rada-
Iglesias et al., 2011). We found that at approximately 33%
(660/2003) of MEF2D-bound sequences, H3K27 is acetylated
and eRNAs are transcribed, suggesting that only a subset of
MEF2D-bound sequences are active enhancers (Figure 6A).
Consistent with these findings, genes near enhancers marked
by H3K27ac and eRNA transcription are more highly expressed
than genes near MEF2D binding sites with no H3K27ac or eRNA
expression (Figure 6B). Furthermore, we find that MEF2D
binding is necessary for full activation of MEF2D target gene
enhancers, as H3K27ac levels and eRNA transcription are
significantly reduced at target gene enhancers in Mef2d KO(C) Aggregate plots of MEF2 consensus binding motif occurrence in a 2 kb wind
peaks that are increased, unchanged, or decreased in Crx KO retinas are shown
summits where MEF2D binding is decreased in Crx KO retinas compared to sites
significantly enriched at sites whereMEF2D binding increases inCrxKO retinas cocompared to WT retinas (Figures 6C and S6A). We observed
that this reduction in H3K27ac and eRNA levels in Mef2d KO
versus WT retinas is more significant at enhancers that are
near target genes than at enhancers not associated with target
genes (p < 3.79e-10 for eRNAs; p < 3.12e-9 for H3K27Ac,
t test). Together, these results show that selective activation
of MEF2D binding sites is an important feature of MEF2D
target gene regulation and that MEF2D is necessary but not
necessarily sufficient for activation of enhancers near MEF2D
target genes.
To determine the mechanism of selective MEF2D enhancer
activation, we considered the possibility that CRX might serve
as a co-activator at MEF2D-bound enhancers, not only at sites
where CRX is required forMEF2D binding, but also at sites where
CRX and MEF2D are bound, but where MEF2D binding is not
dependent upon CRX. To test this hypothesis, we first asked
whether CRX binding correlated with enhancer activity at
MEF2D-bound sites. When assessed across the genome, the
MEF2D-bound enhancers that are co-bound by CRX were
found to be significantly more active (enriched for H3K27ac
and eRNA expression) than the MEF2D enhancers where CRX
was not bound, even when the amount of MEF2D binding is
the same (Figure 6D). This strongly suggests that the presence
of CRX together with MEF2D is required for the maximal activa-
tion of MEF2D-bound enhancers in photoreceptors. However,
MEF2D does not appear to be a required co-factor for the acti-
vation of CRX-bound enhancers as the majority of active CRX-
bound sites do not bind MEF2D and because H3K27ac levels
and eRNA expression are similar at sites where CRX and
MEF2D are both bound and where CRX is bound alone (data
not shown).
To determine whether CRX co-binding is required for the
selective activation of MEF2D-bound regulatory elements, we
performed RNA-seq in WT and Crx KO retinas at P11 and quan-
tified the levels of eRNAs at MEF2D-bound enhancers genome-
wide (Figures 6E and 6F). We found that CRX is required for
the majority of eRNA expression at MEF2D-bound enhancers
and that this is observed both at the population level and at
individual enhancers (Figures 6E and 6F). These sites include
nearly all the active sites where MEF2D binding is dependent
upon CRX (97%) as well as the majority of active, CRX and
MEF2D co-bound sites where MEF2D is not dependent on
CRX for binding (73%) (Figure S6B). These latter sites include
enhancers of clinically relevant MEF2D target genes such as
Pcdh15, Guca1a, and Guca1b (Figure 6C and data not shown).
Furthermore, the level of eRNA transcription at MEF2D binding
sites shared across tissues (Figure 3B) is low and not signifi-
cantly affected by deletion of CRX, consistent with our observa-
tion that there is a low level of CRX binding at these sites. Taken
together, these results indicate that CRX is required for the
selective activation of MEF2D-bound regulatory elements not
only because CRX recruits MEF2D to tissue-specific enhancers,ow centered on summits of MEF2D-bound sites. Motif enrichments at MEF2D
. The MRE is significantly de-enriched within a 400 bp window of MEF2D peak
where MEF2D binding is unchanged (chi-square test; p < 0.002). The MRE is
mpared to sites whereMEF2D binding is unchanged (chi-square test: p < 0.05).
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Figure 6. CRX Determines the Selective Activation of MEF2D-Bound Retinal Enhancers
(A) Aggregate plots of H3K27Ac ChIP-seq signal (top) and eRNA expression (bottom) at active (n = 660) or inactive (n = 584) MEF2D-bound enhancers (reads per
bp per peak). Plots are centered on summits of MEF2D-bound regions that are >1 kb away from the nearest gene TSS.
(B) Cumulative distribution of WT average exon density (from RNA-seq data, n = 2) for genes nearest active enhancers (red) versus genes nearest inactive
enhancers (black) (KS test; p = 9.73e-17).
(legend continued on next page)
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Figure 7. MEF2D and CRX Coordinately
Regulate Gene Expression Necessary for
Photoreceptor Development and Function
through Tissue-Specific Enhancer Co-Bind-
ing and Co-Activation
In WT photoreceptors, CRX recruits MEF2D to-
ward retina-specific enhancers without MEF2D
consensus binding sites at the expense of non-
retinal enhancers with high-affinity consensus
binding sites (MREs). Once bound, MEF2D and
CRX selectively activate retina-specific enhancers,
as determined by enriched H3K27ac (Ac) and
eRNA expression, to drive shared target genes
that are required for photoreceptor outer segment
development and phototransduction. MEF2D is
required for retinal enhancer activation and
photoreceptor gene expression, leading to a fail-
ure of photoreceptor development and photo-
transduction in Mef2d KO photoreceptors. In the
CRX KO, MEF2D binding is lost at retina-specific
enhancers without consensus MREs and recruited
back to non-retinal enhancers with consensus
MREs resulting in a loss of gene expression
necessary for photoreceptor development and
function and an increase in expression of non-
retinal genes.but also because CRX directly co-activates MEF2D-bound
enhancers.
While other mechanisms undoubtedly contribute to the func-
tion of MEF2D in the retina, the data presented in this study high-
light two distinct mechanisms by which MEF2D, a broadly ex-
pressed TF, achieves cell-type-specific function in retinal
photoreceptor development (Figure 7). First, MEF2D is recruited
away from non-retinal consensus binding sites toward retina-(C) The Pcdh15 genomic locus in WT andMef2d KO retinas with ChIP-seq tracks for MEF2D and H3K27Ac a
enhancer is highlighted in gray.
(D) Top: aggregate plots of H3K27Ac ChIP-seq signal at enhancers bound by MEF2D alone (left) versus tho
(Student’s t test; p = 4.79e-65). Middle: aggregate plots of eRNAs at enhancers bound byMEF2D alone (left) v
retinas. Bottom: aggregate plots of MEF2D ChIP signal (purple) or CRX ChIP signal (blue) for same region
MEF2D peak size and differential peak size of CRX.
(E) Average eRNA expression at individual MEF2D-bound enhancers in WT versus Crx KO retinas. n = 2 for e
400 bp window centered on the summit of eachMEF2D-bound region. Gray line indicates unity. Expression of
less than 0.5 is indicated with red points.
(F) Expression of eRNAs at a putative enhancer bound by MEF2D and CRX upstream of the Tnfaip3 genom
RNA-seq tracks and ChIP-seq tracks for MEF2D and CRX in WT retinas. eRNA expression and MEF2D and C
in gray.
Neuron 86, 247–specific enhancers and CRX stabilizes
MEF2D binding at those enhancers where
the MRE is particularly weak. Second,
MEF2D cooperates with CRX to co-acti-
vate retina-specific enhancers as deter-
mined by increased H3K27Ac levels and
eRNA production. Through these mecha-
nisms, MEF2D achieves tissue-specific
function in the development of the mouse
retina. Disruption of these mechanisms
leads to misregulated expression of crit-
ical cell-type-specific genetic programs,a failure of photoreceptor cell development, and ultimately to a
loss of visual function.
DISCUSSION
In this study, we identify retinal photoreceptors as a neuronal cell
type in the CNS that predominantly expresses a single MEF2
family member, MEF2D, during development and that requiresnd RNA-seq tracks. The upstream MEF2D-bound
se bound by MEF2D and CRX (right) in WT retinas
ersus those bound byMEF2D and CRX (right) in WT
s, demonstrating normalization of data analysis to
ach genotype. Read density was calculated for the
eRNAs whereCrx KO/WT expression was equal or
ic locus in WT, Mef2d KO, and Crx KO retinas with
RX binding in the upstream enhancer is highlighted
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MEF2D cell autonomously for functional differentiation in vivo.
MEF2 TFs have been previously proposed to play a role in pho-
toreceptors (Escher et al., 2011; Hao et al., 2011), but evidence
for this has proved elusive until now. Our analyses demonstrate
that MEF2D regulates photoreceptor cell development by
binding to and activating photoreceptor-specific enhancers
and thereby regulating critical photoreceptor-specific genes
including genes that are mutated in human retinal disorders.
Within the CNS, retinal photoreceptors are notable because
they are a homogeneous and functionally well-characterized
cell type that makes up the majority of cells in the retina. This
made it possible to perform genomic and epigenetic analyses
in vivo to functionally dissect the mechanisms by which
MEF2D regulates photoreceptor development.
Although it is broadly expressed across many tissues, we find
that MEF2D binds to and selectively activates retina-specific
enhancers with the retina-specific homeodomain TF CRX and
that cooperation with CRX is critical for the tissue-specific func-
tion of MEF2D through two distinct mechanisms. First, CRX
recruits MEF2D to photoreceptor-specific enhancers that lack
a consensus MRE. This suggests that CRX actively stabilizes
MEF2D binding rather than functioning solely as a pioneer factor
that opens up chromatin to reveal MREs. It remains to be deter-
mined whether MEF2D recruits CRX in a similar manner,
although preliminary motif analyses suggest that this may not
occur, as the majority of both CRX enhancers co-bound with
MEF2D and those without MEF2D contain a consensus CRX
DNAbindingmotif (83.17%versus 84.16%). Second, CRXworks
cooperatively with MEF2D to selectively co-activate CRX/
MEF2D co-bound enhancers as determined by increased
H3K27Ac levels and eRNA production at enhancers when both
MEF2D and CRX are bound. Importantly, the cooperative action
of MEF2D and CRX determines the subset of MEF2D-bound
sites that are active enhancers among the thousands of
MEF2D binding sites in photoreceptors.
This type of cooperative interaction may also be important for
other cell types that express MEF2 factors, as CRX is closely
related to two other homeobox factors OTX1 and OTX2 that
are critical for the development of the CNS and are expressed
inmany non-neuronal cell types. Alternatively MEF2 familymem-
bers may interact with distinct TF families in different cell types.
We find that myocyte-specific MEF2D-binding sites are highly
enriched for a tissue-specific cofactor motif, the myogenic
bHLH recognition element. Indeed, previous in vitro reporter
studies have suggested that MEF2 may interact with myogenic
bHLH heterodimers during muscle differentiation (Molkentin
et al., 1995).
It will be of particular interest to determine the generality of our
finding that a tissue-specific factor (CRX) can bias the binding of
a widely expressed TF (MEF2D) so that the two TFs function
together at tissue-specific enhancers. Previous work has
demonstrated a competition between functional DNA binding
sites and non-functional binding sites in satellite regions and re-
petitive DNA, which are thought to limit free TF concentration in
the nucleus (Liu et al., 2007). Our results suggest that CRX biases
the genome-wide competition forMEF2D binding toward regula-
tory sites that are relevant to photoreceptor gene expression and
that in the absence of CRX, MEF2 binding increases at MREs260 Neuron 86, 247–263, April 8, 2015 ª2015 Elsevier Inc.that are not normally bound by MEF2 in the retina, thereby
inducing expression of nearby genes. However, these newly
bound sites are not merely sponges that limit available MEF2D
but are highly conserved and appear to regulate MEF2 target
gene expression in other cell types (Nakagawa et al., 2005).
Once bound to the genome, we find that additional mecha-
nisms must regulate the action of MEF2 function because only
a small subset of the several thousand MEF2D binding sites
are required for expression of nearby genes. We found that
selective activation of a subset of MEF2D-bound enhancers
plays a significant role in determining which genes require
MEF2D for their expression and that CRX contributes to this
selective activation. In non-neural tissues, MEF2 co-factors
have been suggested to help recruit co-activators such as his-
tone acetyltransferases (HATs) (Youn et al., 2000). As CRX binds
the HAT P300 (Yanagi et al., 2000), this raises the possibility that
in photoreceptors MEF2D and CRX cooperatively recruit HATs
to form a MEF2D-HAT-CRX complex. Such a tripartite complex
may also stabilize MEF2D binding, in which case a single mech-
anism could account for the contribution of CRX to MEF2D
binding and selective activation of MEF2D-bound regulatory
elements. The majority of MEF2D binding in the retinal genome,
however, occurs at sites that appear to be non-functional,
because they lack marks of enhancer activity (e.g., eRNAs and
H3K27ac). Nonetheless, this binding may be functionally signifi-
cant through other mechanisms of action. Notably, MEF2 TFs
are known to function in a stimulus-dependent manner else-
where in the CNS (Flavell et al., 2006; Shalizi et al., 2006) and it
is possible that MEF2D in photoreceptors could regulate
enhancers in a dynamic manner. While future studies are
required to test this hypothesis, it is interesting that many of
the direct MEF2D target genes that have been identified in this
study have been shown to be strongly regulated in photorecep-
tors by light and/or by the circadian clock (Storch et al., 2007).
The findings presented in this study contribute towork that has
been done previously to elucidate the network of TFs that are
critical for photoreceptor development. While TFs such as
CRX, NRL, and NR2E3 are known to be highly tissue specific,
MEF2D is broadly expressed but achieves photoreceptor-
specific function through interactions with CRX. Thus, the role
of tissue-specific TFs in photoreceptor development is not
simply to activate target gene expression, but also to recruit
potent transcriptional regulators such as MEF2 toward photore-
ceptor functions by directly competing MEF2D away from non-
retinal enhancers and by selectively activating photoreceptor
enhancers with MEF2D. Furthermore, the loss of CRX does not
simply result in the loss of CRX target gene expression,
but also results in the redistribution of MEF2D toward non-
retinal specific enhancers to activate other programs of gene
expression.
Finally, the present study suggests that MEF2D has the poten-
tial to be important in human retinal disease. MEF2D co-regu-
lates critical retinal disease genes with CRX, which itself
is mutated in several retinal diseases characterized by photore-
ceptor degeneration. Importantly, the identification of active
photoreceptor enhancers allowed us to identify critical
MEF2D-bound functional regulatory elements, which can be as
much as 100 kb away from the transcriptional start site of retinal
disease genes. This is significant as these regulatory elements
may correspond to sites of genetic variation in humans and
may ultimately be found to harbor disease-causing mutations.
For example, SNPs in these regulatory elements that affect the
binding of MEF2D or CRX might disrupt enhancer activity and
nearby gene expression, leading to retinal disease. Such muta-
tions would join a growing cohort of enhanceropathies that
contribute to human disease (Smith and Shilatifard, 2014).
Thus, these genome-wide analyses provide a rich resource for
considering how non-coding regulatory regions function in
normal development of the retina and potentially in human
disease.
EXPERIMENTAL PROCEDURES
A full description of the experimental procedures is included in the Supple-
mental Experimental Procedures.
Generation of Mef2d Knockout and Conditional Knockout Mice
Targeting of the Mef2d locus was carried out by homologous recombination
in ES cells (Figure S1). Successfully targeted mice were then crossed to
EIIA-Cre-expressing mice (stock number 003724; The Jackson Laboratory)
and offspring were analyzed for expression of the presence of Cre and
the state of the targeted Mef2d allele. Mice with the neomycin cassette
deleted and with transmission of either the floxed allele or the null allele
were crossed into a C57Bl/6 background and used to establish the knockout
and conditional knockout lines used in this study. The Institutional Animal Care
and Use Committee at Harvard University approved all of the experiments in
this study.
RNA-Seq
Total RNA was extracted from two P11 mouse retinas per sample. RNA was
submitted to BGI (Shenzhen, China) for library construction and sequencing.
Libraries were sequenced to a depth of at least 83 107 clean reads per sample
on the Illumina Hiseq 2000 platform.
ChIP-Seq
ChIP antibodies used were anti-MEF2D (Flavell et al., 2008) and anti-H3K27Ac
(AbcamAB4729). MEF2DChIP frommouse cortical cultures was performed as
described (Kim et al., 2010). MEF2D and H3K27Ac ChIP from mouse retinas
was performed as described for brain tissue (Hong et al., 2008) with modifica-
tions (Supplemental Experimental Procedures). Immunoprecipitated chro-
matin was submitted to BGI for library construction and sequencing on the Il-
lumina Hiseq 2000 platform. For each sample, >20 million clean reads were
obtained. Sequencing reads were aligned to the mouse genome (NCBI 37,
mm9) using the Burrows-Wheeler Aligner.
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Note Added in Proof
Since the submission of this manuscript, a recent study by Omori et al. (2015)
corroborates the requirement for Mef2d in the maturation and survival of
mouse photoreceptors:
Omori, Y., Kitamura, T., Yoshida, S., Kuwahara, R., Chaya, T., Irie, S., and
Furukawa, T. (2015). Genes Cells. Published online March 11, 2015. http://
dx.doi.org/10.1111/gtc.12233.Neuron 86, 247–263, April 8, 2015 ª2015 Elsevier Inc. 263
